$0.253
-0.004 (-1.60%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
VTGN 相似图表分析预测
Alphio's VTGN stock price prediction model matches the current Vistagen Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.25 (-0.34%). The 1-week path is $0.27 (+4.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Vistagen Therapeutics Inc 股票吗？
Vistagen Therapeutics is currently not a strong buy. The stock is trading at $0.2529, and while it has shown a 3.65% increase over the past five days, it has a staggering year-to-date decline of 62.75%. The RSI is at 48.935, indicating a neutral position, and the forward P/E ratio is 0, reflecting uncertainty in future earnings. The main risk is the recent trial failure which caused a significant drop in stock price, highlighting potential volatility ahead.
VTGN 股价于 Friday 收于 $0.25，此前下跌 -1.60%
Vistagen Therapeutics Inc (VTGN) last closed at $0.2529, losing -1.60%. These facts feed the 1-day and 1-week VTGN price prediction above.
分析师一致预期
Vistagen Therapeutics Inc（VTGN）：买入 1、持有 0、卖出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
预测驱动因素
Vistagen Therapeutics Inc（VTGN）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 VTGN 最接近的股票，按相似度排序。
VTGN 季节性分析
Historically the probability of a positive August return for VTGN is 3.17%. October offers the highest probability of a positive month at 50.00%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。